tiprankstipranks
Better Therapeutics, Inc. (BTTX)
OTHER OTC:BTTX
US Market

Better Therapeutics, Inc. (BTTX) Financial Statements

Compare
170 Followers

Better Therapeutics, Inc. Financial Overview

Better Therapeutics, Inc.'s market cap is currently $10.87K. The company's EPS TTM is $-1.157; its P/E ratio is ―; Better Therapeutics, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 8.00K$ 18.00K
Gross Profit$ -2.73M$ -1.62M$ -674.00K$ -880.00K
Operating Income$ -38.26M$ -30.56M$ -6.32M$ -5.77M
EBITDA$ -38.26M$ -30.56M$ -6.25M$ -5.70M
Net Income$ -39.76M$ -40.34M$ -6.39M$ -5.79M
Balance Sheet
Cash & Short-Term Investments$ 15.74M$ 40.57M$ 123.00K$ 757.00K
Total Assets$ 22.94M$ 50.96M$ 6.39M$ 4.88M
Total Debt$ 14.88M$ 9.51M$ 640.00K$ 5.00M
Net Debt$ -860.00K$ -31.06M$ 517.00K$ 4.24M
Total Liabilities$ 23.84M$ 14.24M$ 13.14M$ 5.49M
Stockholders' Equity$ -899.00K$ 36.72M$ -6.76M$ -605.00K
Cash Flow
Free Cash Flow$ -30.11M$ -31.89M$ -8.08M$ -8.95M
Operating Cash Flow$ -28.93M$ -30.82M$ -5.77M$ -6.22M
Investing Cash Flow$ -1.18M$ -1.07M$ -2.31M$ -2.74M
Financing Cash Flow$ 5.28M$ 72.33K$ 7.45M$ 8.70M
Currency in USD

Better Therapeutics, Inc. Earnings and Revenue History

Better Therapeutics, Inc. Debt to Assets

Better Therapeutics, Inc. Cash Flow

Better Therapeutics, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis